Silberstein Alzheimer’s Institute
In the 1980s, through the generosity of William and Sylvia Silberstein and the Silberstein Foundation, a dedicated research center to study Alzheimer’s disease and memory disorders was formed at ٺƵ: the world-renowned Silberstein Alzheimer’s Institute.
Located within ٺƵ’s , the Silberstein Alzheimer’s Institute focuses on the prevention, diagnosis, and treatment of Alzheimer’s disease and age-related cognitive decline through research, public education, and clinical care. The Silberstein Alzheimer’s Institute houses the National Institutes of Health (NIH) , the Pearl I. Barlow Center for Memory Evaluation and Treatment, translational research programs, and provides support programs for caregivers.
The ARDC conducts research into Alzheimer’s disease and related disorders, as well as clinical trials into new medications and treatments for memory loss. Of the 37 NIH-supported ADRCs, ours is one of the oldest and largest in the United States and has been funded by the National Institute on Aging for 28 years.
Through the ADRC at the Silberstein Alzheimer’s Institute, patients can participate in a long-term study examining the progression of Alzheimer’s disease. The ADRC provides treatment and care for participants with memory disorders caused by neurological, psychological, and physical ailments, as well as memory issues resulting from the normal aging process.
Patients participating in our clinical trials receive treatment for their condition through the Pearl I. Barlow Center for Memory Evaluation and Treatment. Now regarded as one of New York City’s most comprehensive diagnostic and treatment centers for patients with memory disorders of all origins, the center delivers the highest level of medical and neurological care.
We also understand that one of the best ways we can help patients is by helping their caregivers. Through our support groups and counseling, we give caregivers the tools they need to maintain their important roles.